OBIO

5.35

10.54% 0.51

Handel nachbörslich: 5.20 -0.15 -2.80%

Orchestra Biomed Holdings Inc (OBIO)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$4.84

Offen:

$4.82

24-Stunden-Volumen:

662.21K

Relative Volume:

2.11

Marktkapitalisierung:

$302.09M

Einnahmen:

$2.76M

Nettoeinkommen (Verlust:

$-49.12M

KGV:

-3.5667

EPS:

-1.5

Netto-Cashflow:

$-46.21M

1W Leistung:

+26.48%

1M Leistung:

+35.10%

6M Leistung:

+96.69%

1J Leistung:

-3.95%

1-Tages-Spanne:

$4.64

$5.40

1-Wochen-Bereich:

$4.15

$5.40

52-Wochen-Spanne:

$2.20

$6.30

Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile

Firmenname

Orchestra Biomed Holdings Inc

Sektor

Healthcare (1134)

Branche

Biotechnology (635)

Telefon

646-343-9298

Adresse

150 UNION SQUARE DRIVE, NEW HOPE

Mitarbeiter

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

OBIO's Discussions on Twitter

Vergleichen Sie OBIO mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
OBIO Orchestra Biomed Holdings Inc	5.35	273.29M	2.76M	-49.12M	-46.21M	-1.50
VRTX Vertex Pharmaceuticals Inc	429.82	107.58B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	787.32	80.03B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	429.80	57.37B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	917.93	55.83B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	209.02	44.13B	447.02M	-1.18B	-906.14M	-6.1812

Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-08-20	Herabstufung	BTIG Research	Buy → Neutral
2025-03-20	Eingeleitet	BTIG Research	Buy
2025-01-02	Eingeleitet	Barclays	Overweight
2024-08-22	Eingeleitet	H.C. Wainwright	Buy
2024-07-25	Eingeleitet	B. Riley Securities	Buy
2024-01-19	Eingeleitet	Jefferies	Buy
2023-02-24	Eingeleitet	Piper Sandler	Overweight
2023-02-07	Eingeleitet	Chardan Capital Markets	Buy

Alle ansehen

Orchestra Biomed Holdings Inc Aktie (OBIO) Neueste Nachrichten

Nov 21, 2025

Orchestra BioMed’s Big Cash Infusion Sets Stage for High-Stakes Cardiology Trials - MSN

Nov 21, 2025

Nov 19, 2025

How currency fluctuations impact Orchestra BioMed Holdings Inc. stockDividend Hike & Low Drawdown Trading Strategies - newser.com

Nov 19, 2025

Will Orchestra BioMed Holdings Inc. stock outperform tech sector in 2025July 2025 Snapshot & Entry and Exit Point Strategies - newser.com

Nov 19, 2025

Orchestra BioMed Study Shows AVIM Therapy Could Transform Care for Hypertensive Heart Disease - MSN

Nov 19, 2025

Exit strategy if you’re trapped in Orchestra BioMed Holdings Inc.July 2025 Selloffs & Weekly Watchlist for Consistent Profits - newser.com

Nov 19, 2025

Nov 18, 2025

Is Orchestra BioMed Holdings Inc. stock supported by strong cash flowsWeekly Stock Summary & Consistent Profit Trade Alerts - newser.com

Nov 18, 2025

Is Orchestra BioMed Ready For Landmark Year With Trial Enrollment And Cash Strength? - RTTNews

Nov 18, 2025

Nov 17, 2025

How sentiment analysis helps forecast Orchestra BioMed Holdings Inc.2025 Volatility Report & Expert Curated Trade Setups - newser.com

Nov 17, 2025

Orchestra BioMed Holdings Director David P Hochman Acquires 5,000 Shares - TradingView

Nov 17, 2025

Chmn Hochman Buys 5,000 ($20.4K) Of Orchestra BioMed Holdings Inc [OBIO] - TradingView

Nov 17, 2025

[Form 4] Orchestra BioMed Holdings, Inc. Insider Trading Activity - Stock Titan

Nov 17, 2025

Is this a good reentry point in Orchestra BioMed Holdings Inc.Day Trade & Free Verified High Yield Trade Plans - newser.com

Nov 17, 2025

Research Analysts Offer Predictions for OBIO FY2025 Earnings - Defense World

Nov 17, 2025

Nov 16, 2025

Barclays Initiates Coverage of Orchestra BioMed Holdings (OBIO) with Overweight Recommendation - MSN

Nov 16, 2025

Will Orchestra BioMed Holdings Inc. stock recover after recent drop2025 Year in Review & Real-Time Stock Price Movement Reports - newser.com

Nov 16, 2025

Nov 14, 2025

Can Orchestra BioMed Holdings Inc. stock withstand economic slowdownJuly 2025 Retail & Safe Swing Trade Setups - newser.com

Nov 14, 2025

Chmn Hochman Surrenders 6,566 Of Orchestra BioMed Holdings Inc [OBIO] - TradingView

Nov 14, 2025

Views of Wall Street’s Leading Experts on Orchestra BioMed Holdings Inc - Setenews

Nov 14, 2025

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Nov 14, 2025

Nov 13, 2025

Orchestra BioMed Kicks Off Pivotal U.S. Trial of Non-Coated Sirolimus Balloon - MSN

Nov 13, 2025

Orchestra BioMed Secures FDA Breakthrough Designation - TipRanks

Nov 13, 2025

Orchestra BioMed Holdings, Inc. Provides Significant Business Updates - TradingView

Nov 13, 2025

[8-K] Orchestra BioMed Holdings, Inc. Reports Material Event | OBIO SEC FilingForm 8-K - Stock Titan

Nov 13, 2025

Orchestra BioMed Holdings Insiders May Regret Not Buying More, Market Cap Hits US$232m - simplywall.st

Nov 13, 2025

Can Orchestra BioMed Holdings Inc. stock reach $100 price target - newser.com

Nov 13, 2025

Nov 12, 2025

Barclays Maintains Orchestra BioMed Holdings (OBIO) Overweight Recommendation - Nasdaq

Nov 12, 2025

Barclays Lowers Price Target for OBIO While Maintaining Overweig - GuruFocus

Nov 12, 2025

Orchestra BioMed Secures $111M to Advance Late-Stage Cardiac Therapies, Hits Multiple FDA Milestones - MSN

Nov 12, 2025

Nov 11, 2025

Orchestra BioMed to Deliver Major Business Update Amid Rapid Clinical Momentum - MSN

Nov 11, 2025

Orchestra BioMed Secures Funding And Upgrades Clinical Plans - Finimize

Nov 11, 2025

Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences - The Manila Times

Nov 11, 2025

Orchestra BioMed (NASDAQ: OBIO) to join Jefferies London and Piper; Dec. 3 fireside chat - Stock Titan

Nov 11, 2025

What To Expect From Orchestra BioMed Holdings Inc (OBIO) Q3 2025 Earnings - Yahoo Finance

Nov 11, 2025

Nov 10, 2025